CINVANTI 130 mg/18mL
aprepitant · INJECTION, EMULSION · Heron Therapeutics, Inc.
No Recall HistoryCurrently in Shortage
Plain English
CINVANTI is a injection, emulsion containing aprepitant at 130 mg/18mL, taken intravenous. Manufactured by Heron Therapeutics, Inc..
Key Facts
- Brand Name
- CINVANTI
- Generic Name
- aprepitant
- NDC Code (Product)
47426-201- Manufacturer
- Heron Therapeutics, Inc.
- Strength
- 130 mg/18mL
- Dosage Form
- INJECTION, EMULSION
- Route
- INTRAVENOUS
- Marketing Status
- Application #
- NDA209296
- Drug Class
- Substance P/Neurokinin-1 Receptor Antagonist [EPC]
- Marketing Start
- 01/03/2018
Recall History
No Recall HistoryFrequently Asked Questions
What is CINVANTI used for?
CINVANTI contains aprepitant. It is a injection, emulsion taken intravenous. Consult your doctor for specific uses.
Is CINVANTI a controlled substance?
CINVANTI is not classified as a controlled substance by the DEA.
What is the generic name for CINVANTI?
The generic name for CINVANTI is aprepitant. There are 11 other brand versions of aprepitant.
What is the NDC code for CINVANTI 130 mg/18mL?
The NDC (National Drug Code) for CINVANTI 130 mg/18mL is 47426-201, listed by Heron Therapeutics, Inc..